CONCERT PHARMACEUTICALS, INC. 4
4 · CONCERT PHARMACEUTICALS, INC. · Filed Jan 6, 2017
Insider Transaction Report
Form 4
Daws D. Ryan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-01-04+82,500→ 82,500 totalExercise: $10.97Exp: 2027-01-03→ Common Stock (82,500 underlying)
Footnotes (1)
- [F1]This option vests in sixteen equal quarterly installments beginning on April 4, 2017.